[go: up one dir, main page]

WO1995024159A1 - Appareil de destruction non invasive des tissus au moyen d'ultrasons - Google Patents

Appareil de destruction non invasive des tissus au moyen d'ultrasons Download PDF

Info

Publication number
WO1995024159A1
WO1995024159A1 PCT/DK1995/000102 DK9500102W WO9524159A1 WO 1995024159 A1 WO1995024159 A1 WO 1995024159A1 DK 9500102 W DK9500102 W DK 9500102W WO 9524159 A1 WO9524159 A1 WO 9524159A1
Authority
WO
WIPO (PCT)
Prior art keywords
ultrasound
housing
power amplifier
lens
power
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK1995/000102
Other languages
English (en)
Inventor
Lars Laurvig Haugaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDISONIC AS
Original Assignee
MEDISONIC AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDISONIC AS filed Critical MEDISONIC AS
Priority to AU18895/95A priority Critical patent/AU1889595A/en
Publication of WO1995024159A1 publication Critical patent/WO1995024159A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/225—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
    • A61B17/2256—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves with means for locating or checking the concrement, e.g. X-ray apparatus, imaging means
    • A61B17/2258—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves with means for locating or checking the concrement, e.g. X-ray apparatus, imaging means integrated in a central portion of the shock wave apparatus

Definitions

  • the invention concerns an apparatus for non-invasive tissue destruction by focused high intensity ultrasound by means of which the tissue in the focal zone of the apparatus is heated to such a high temperature that the tissue is de ⁇ stroyed.
  • This therapy is called pyrotherapy and is used for local ⁇ ized strong heating of small tissue areas with a view to performing localized tissue destruction of e.g. tumours.
  • the treated tissue is typically heated to a temperature which is higher than 60 °C.
  • Ultrasound for medical diagnosis and therapy typically em ⁇ ploys frequencies in the range from 1 MHz to 10 MHz.
  • the ultrasound signals are usually generated by piezoelectric ceramic elements on which two electrodes are applied, and which have the property that when an electric voltage is applied to the electrodes, the piezoelectric element changes its physical dimensions, e.g. thickness.
  • a piezoe ⁇ lectric element has a mechanical resonance frequency for this dimensional change, and the resonance frequency of the element is excited by means of electric signals.
  • the piezoelectric elements are constructed such as to have a well-defined resonance in the above-mentioned frequency range, the resonance frequency being selected according to the purpose.
  • vibrations from vibrating piezoelectric elements are conducted in the form of ultrasound into the body of a human or an animal in which the ultrasound signals propa ⁇ gate.
  • the ultrasound signals propagate in the tissue concerned, the ultrasound energy is partly absorbed in the tissue and converted into heat, and is partly reflected and dispersed.
  • Ultrasound is used i.a. for image diagnostic purposes , where ultrasound signals are transmitted from an ultrasound transducer into the body of a human. These ultrasound sig ⁇ nals consist of short ultrasound pulses, each of which has a duration of 1-5 periods of the resonance frequency. The pulses are repeated with a pulse/pause ratio of the order of 1/1000. In the pause between emission of ultrasound pulses, the ultrasound transducer is adapted to serve as a receiver of ultrasound pulses which are reflected at acous ⁇ tic impedance changes in the tissue. Ultrasound pulses hav ⁇ ing relatively low ultrasound energy peak values are used here. The average intensity of the ultrasound pulses for diagnostic ultrasound does not exceed 200 W/cm . Owing to the long pauses between ultrasound pulses the average den ⁇ sity of the ultrasound is very low. Time averaged intensi ⁇ ties do not exceed 750 .
  • Ultrasound is also used therapeutically to crush or disin ⁇ tegrate e.g. kidney stone and gallstone. See e.g. EP 367 117 and US 5 065 762.
  • Devices for this purpose use focused discrete short shock waves having very high intensities. But the average value of the ultrasound intensity is rela ⁇ tively low, so no noticeable heating occurs.
  • the ultrasound source generates a focused shock wave, and the shock wave results in a very strong shock (> 1000 bars) in the focal zone, which passes relatively unobstructedly through homogeneous tissue. If the focal zone of high energy inten ⁇ sity includes material having another acoustic impedance than the surrounding tissue, e.g. a kidney stone, the shock wave interacts with this material.
  • Shock waves may be generated for this purpose by means of spark discharges, microexplosions, electrohydraulic equip ⁇ ment or with piezoelectric elements.
  • piezoelectric elements When piezoelectric elements are used, these are charged with a high voltage, and they are then short-circuited, whereby the resonance frequency of the elements is excited. Voltages of 10-20 kV are used for this, which for medicinal use requires special care for reasons of safety.
  • Continuous ultrasound waves are used for other therapeutic purposes, partly for hyperthermia, where slight heating, either localized or of entire organs, is performed by means of the absorbed ultrasound energy.
  • Ultrasound hyperthermia is used partly in the same manner as short wave therapy for the treatment of myalgia or in connection with chemother- apy.
  • continuous ultrasound waves are also used for the present form of therapy, viz. pyrotherapy. See e.g. US 5 150 711.
  • the ultrasound has a frequency in the range 0.2 to 3.0 MHz. Low frequencies give a large penetration depth owing to poor attenuation in the tissue, while high frequencies give a good focusing owing to small wavelengths.
  • the sound waves emanate convergingly from the ultrasound source which has focusing means, and a high sound pressure exists in the focal zone because of the me ⁇ chanical focusing and constructive interference.
  • the con ⁇ stant sound pressure of relatively high intensity leads to heating of the tissue in the focal zone. Heating to tem ⁇ peratures below 43 °C (hyperthermia) does not result in damage to the tissue, while the cells of the tissue are de ⁇ stroyed at temperatures above 60 °C (pyrotherapy).
  • Intensi ⁇ ties above 700 W/cm 2 and an ultrasound frequency of 1 MHz moreover results in cavitation which causes implosion of microboubles in the tissue. These microboubles grow under the influence of the sound field until they reach a criti ⁇ cal size where they abruptly collapse and tear holes in the surrounding cell walls.
  • Continuous ultrasound waves for pyrotherapy are generated by means of piezoelectric elements to which an electric voltage is applied, having a frequency corresponding to the resonance frequency of the piezoelectric elements, thereby causing the elements to vibrate with their resonance fre- quency.
  • An apparatus where the power amplifier handling the electric power signals at ultrasound frequency is arranged in the housing with the ultrasound head and the ultrasound generating means, provides effective electromagnetic shielding in a particularly simple manner, as the electric wires from the power ampli ⁇ bomb to the piezoelectric elements may hereby be made very, short with a consequent lower electromagnetic radiation than in the case of long cables.
  • the short wires also mean that power losses caused by o ⁇ herwise necessary electric adapters are eliminated.
  • the housing with the ultrasound heed may be made as a closed box of metal or another electrically conducting ma- terial and be connected electrically to the focusing lens, which may likewise be of metal, so that these parts form a substantially closed enclosure of the power amplifier and the piezoelectric elements, which are hereby completely shielded.
  • the external wires to this housing will typically then merely be cables for power supply and signal cables passing signals at low current and voltage levels, and which will therefore not emit noticeable electromagnetic noise.
  • fig. 1 is a schematic view of the structure of an ultra ⁇ sound head according to the invention.
  • fig. 2 is a schematic view of a block diagram of a complete system according to the invention.
  • the ultrasound head in figure 1 comprises a housing 10 which forms a completely closed compartment. However, up ⁇ wardly in the figure, the housing 10 is shown to be non- terminated, as various electric connections for the ultra ⁇ sound head are provided here, as will appear from the fol ⁇ lowing.
  • the housing 10 of the ultrasound head has an outer contact face 11, which is the outer side of an ultrasound transparent diaphragm or plate 12, which is preferably flexible and optionally has a central hole (an open bel ⁇ lows). In use, the contact face 11 is arranged as shown in fig. 2 against the skin of a person 60 to be treated.
  • the housing 10 Behind the diaphragm with the contact face 11 the housing 10 accommodates a compartment 13 which, op ⁇ posite the diaphragm 12, is defined by a plane-concave acoustic lens 20 whose concave side 21 faces the compart ⁇ ment 13.
  • the lens 20 is made of metal, such as aluminium, or a suitable plastics material, and the lens is rotation- ally symmetrical about an axis 24.
  • a plurality of piezoelectric elements 30 are arranged con ⁇ centrically about the axis of rotational symmetry 24 of the lens on the place side 22 of the lens 20, said piezoe ⁇ lectric elements being arranged close to the plane side 22 ⁇ of the lens and in good acoustic contact with it.
  • the pie- zoelectric elements are discs which are constructed to have a resonance frequency of about 1 MHz at vibrations trans ⁇ versely to the plane of the discs.
  • the acoustic contact with the lens may be ensured e.g. by gluing the piezoelec ⁇ tric lenses 30 on the plane face 22 of the lens, or, as shown, by providing a disc 31 of cork or another air-filled and reasonably dimensionally stable material, e.g.
  • the acoustic contact medium between the piezoe- lectric elements 30 and the plane face 22 of the lens may be an acoustically conducting or transparent material, such as e.g. oil, fat, paste or another suitable material.
  • a mechanical fixing block 32 of aluminium serves to mechanically fix the cork discs 31 and the piezoelectric elements 30 and to electrically connect these, since the cork discs 31 may be wound with e.g. a layer of aluminium sheet which provides contact between the piezoelectric ele ⁇ ments 30 and the mechanical fixing block 32.
  • a gap is shown here between the piezoelectric elements 30 and the cork discs 31 and between the cork discs 31 and the mechanical fixing block 32, but in practice these are posi ⁇ tioned close to each other.
  • the housing 10 ac ⁇ commodates power amplifier modules 40 which supply the piezoelectric elements 30 with electric energy in the form 1 MHz square wave signals.
  • the preferred embodiment in ⁇ cludes four such power amplifier modules 40, each of which supplies a plurality of piezoelectric elements 30 with up to 250 W square wave signals at the fundamental frequency of about 1 MHz. Electric contact is created between the power amplifier module 40 and the mechanical fixing blocks 32 when these are assembled mechanically.
  • each piezoelectric element 30 has an acoustic impedance owing to their content of air which causes acoustic mismatch between the me ⁇ chanical fixing blocks 32 and the piezoelectric elements 30. Therefore, no ultrasound energy is transmitted up into the mechanical fixing blocks 32.
  • the piezoelectric elements 30 vibrate at their resonance frequency, which is chosen to be about 1 MHz in this case, the acoustic energy in the form of ultrasound will be transmitted into the plane face 22 of the lens 20, and the acoustic energy will emerge from the concave face 21 of the lens and enter the compartment 13, which is filled with an acoustically trans ⁇ parent transmission medium, such as e.g. water.
  • Water has an acoustic impedance which approximately corresponds to the acoustic impedance in soft part tissue in the human body with which the contact face 11 of the diaphragm 12 gets into contact.
  • the ultrasound energy When acoustic contact has thus been established with a hu- man body for treatment, the ultrasound energy will be con ⁇ centrated in a focal zone 25, and the acoustic components of the apparatus and in particular the lens 20 may be di ⁇ mensioned so that the focal zone 25 has a well-defined ex ⁇ tent and location with respect to the apparatus.
  • the energy density of the ultrasound is very high in the focal zone 25, and since the energy absorption in the tissue is proportional to the energy density, the tissue in the focal zone 25 absorbs most ultrasound energy with a consequently stronger heating than elsewhere.
  • the lens 20 has a central opening 26 through which an ul ⁇ trasound transducer 50, in principle of a known type, runs.
  • the ultrasound transducer 50 is used for imaging by means ⁇ of ultrasound and is run to the vicinity of the diaphragm 12.
  • the front face 51 of the ultrasound transducer 50 is an acoustic window for the transducer 50, which forms images of tissue present within a sector-shaped image field 52 by means of ultrasound in a known manner.
  • the imaging ultrasound transducer 50 is arranged so as to be capable of rotating about the axis 24, and any axial plane can hereby be imaged in a conical volume with the sector-shaped image field 52.
  • the location of the focal zone with respect to the imaging ultrasound transducer 50 is well-defined, and the focal zone 25 may then be marked electronically on ultrasound im ⁇ ages recorded by means of the transducer 50.
  • the imaging transducer 50 is used in a known manner for localizing the place to be treated and for monitoring the treatment as it proceeds.
  • the treatment may be monitored, and it may hereby be detected whether the place to be treated moves during the treatment. Internal organs may be displaced, e.g. be ⁇ cause of respiration. It may also be currently monitored whether the focal zone 25 is at the expected place in the body. This is important for reasons of patient safety.
  • Electric wires to the power amplifier modules 40 are not shown in fig. 1, but are run through a suitable opening in the housing 10, e.g. upwardly in the drawing.
  • the housing 10 is in electric connection with the lens 20, and prefer- ably in such a manner as to form a compartment which com ⁇ pletely encloses the piezoelectric elements 30, the cork discs 31, the mechanical fixing blocks 32 and the power am ⁇ plifier modules 40.
  • the housing 10, together with the lens 20, forms a substantially completely closed electric en- closure, which provides good electromagnetic shielding.
  • Fig. 2 schematically shows a block diagram of a complete system for pyrotherapy according to the invention.
  • the compartment 13, which contains degassed water, is here lat- erally defined by a bellows 14 causing the housing 10 with the imaging transducer 50 to be movable axially with re ⁇ spect to the person 60 who is to be treated.
  • a computer system controls all functions in the system, and the user can communicate with the computer system by means of a user interface, e.g. in the form of a keyboard for the computer system.
  • An ultrasound monitor communicates with the com ⁇ puter system and receives electric signals from the imaging transducer 50, and the ultrasound monitor displays ultra ⁇ sound images which are recorded by the transducer 50.
  • the ultrasound monitor displays the location of the focal zone 25 superimposed on the ultrasound image, so that it can be currently observed whether the focal zone is placed cor ⁇ rectly with respect to the tissue to be treated.
  • the focusing lens 20 (and the housing 10) may be positioned correctly with respect to the patient 60, such that the focal zone 25 may be placed accurately in the tissue to be treated. This is checked and monitored on the ultrasound monitor. If it is found on the ultrasound monitor that the focal zone is not in the region to be treated, or the focal zone is to be moved to a new region, the position of the lens is adjusted by means of the positioning system monitored by the ultrasound monitor.
  • a DC power supply is arranged outside the housing 10 and supplies DC energy to the power amplifier modules 40 in the housing 10.
  • a control signal generator which is controlled by the computer system, supplies control signals to the power amplifier modules 40.
  • the control signals from the control signal generator are here in the form of logical signals or ON/OFF signals, which control the power amplifier modules 40 to either operate at full, continuous power or to be disconnected.
  • the power amplifier modules 40 comprise an ultrasound frequency generator which, when the control signals are ON, generates a 1 MHz square wave signal which is amplified and passed to the piezoelectric elements 30, and when the control signal is OFF, no such ultrasound signal is generated. All high energy ultrasound signals are thus contained and enclosed in the housing 10, which forms an electric shield.
  • the degassed water which serves as an ultrasound transmis ⁇ sion medium in the compartment 13, is degassed in a de ⁇ gassing apparatus and is circulated between this system and the compartment 13.
  • the circulating degassed water may possibly be used for cooling the power amplifier modules 40.
  • Integration of the power amplifier modules 40 in the hous- ing 10 ensures that operation takes place everywhere at relatively low voltages, typically below ⁇ 50 V, and all high power ultrasound signals are completely enclosed and shielded in the housing 10. This results in an extremely effective shielding and means that the high energy ultra ⁇ sound signals are not to be passed through long cables which must necessarily be shielded owing to the content of high frequencies in the signals. Accordingly, the electro ⁇ magnetic radiation is extremely low, and the entire appa ⁇ ratus therefore has high electromagnetic compatibility. Further, all electric signals are kept at the rear side of the lens 20, which, together with the housing 10, is held at a fixed zero reference potential. The patient is there ⁇ fore not subjected to electric voltages, which results in a high safety for the patient.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • Mechanical Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgical Instruments (AREA)

Abstract

Appareil pour la destruction non invasive des tissus par ultrasons également appelé appareil de 'pyrothérapie'. Des éléments piézo-électriques génèrent des ultrasons qui sont focalisés, p. ex. par une lentille, dans un foyer externe sur le corps à traiter. La tête émettrice d'ultrasons est pourvue de modules d'amplification alimentant les éléments piézo-électriques en énergie électrique.
PCT/DK1995/000102 1994-03-07 1995-03-07 Appareil de destruction non invasive des tissus au moyen d'ultrasons Ceased WO1995024159A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU18895/95A AU1889595A (en) 1994-03-07 1995-03-07 Apparatus for non-invasive tissue destruction by means of ultrasound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK0264/94 1994-03-07
DK26494 1994-03-07

Publications (1)

Publication Number Publication Date
WO1995024159A1 true WO1995024159A1 (fr) 1995-09-14

Family

ID=8091582

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1995/000102 Ceased WO1995024159A1 (fr) 1994-03-07 1995-03-07 Appareil de destruction non invasive des tissus au moyen d'ultrasons

Country Status (2)

Country Link
AU (1) AU1889595A (fr)
WO (1) WO1995024159A1 (fr)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725494A (en) * 1995-11-30 1998-03-10 Pharmasonics, Inc. Apparatus and methods for ultrasonically enhanced intraluminal therapy
US5728062A (en) * 1995-11-30 1998-03-17 Pharmasonics, Inc. Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers
US5735811A (en) * 1995-11-30 1998-04-07 Pharmasonics, Inc. Apparatus and methods for ultrasonically enhanced fluid delivery
US5846218A (en) * 1996-09-05 1998-12-08 Pharmasonics, Inc. Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US5931805A (en) * 1997-06-02 1999-08-03 Pharmasonics, Inc. Catheters comprising bending transducers and methods for their use
US6221038B1 (en) 1996-11-27 2001-04-24 Pharmasonics, Inc. Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers
US6228046B1 (en) 1997-06-02 2001-05-08 Pharmasonics, Inc. Catheters comprising a plurality of oscillators and methods for their use
US6464660B2 (en) 1996-09-05 2002-10-15 Pharmasonics, Inc. Balloon catheters having ultrasonically driven interface surfaces and methods for their use
WO2006072199A1 (fr) * 2005-01-10 2006-07-13 Chongqing Haifu(Hifu)Technology Co., Ltd Appareil a transducteur integral pour traitement ultrasonore
US7637877B2 (en) 2003-04-16 2009-12-29 Siemens Aktiengesellschaft Ultrasonic shock wave head for use in lithotripsy
FR2984172A1 (fr) * 2011-12-16 2013-06-21 Siemens Medical Solutions Systeme de therapie par ultrason pour une utilisation avec un systeme a resonance magnetique
JP2013527782A (ja) * 2010-04-22 2013-07-04 ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション 結石を検出し、その除去を促進する超音波ベースの方法及び装置
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
US9522290B2 (en) 2004-10-06 2016-12-20 Guided Therapy Systems, Llc System and method for fat and cellulite reduction
US9533175B2 (en) 2004-10-06 2017-01-03 Guided Therapy Systems, Llc Energy based fat reduction
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US9694211B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US9895560B2 (en) 2004-09-24 2018-02-20 Guided Therapy Systems, Llc Methods for rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US9974982B2 (en) 2004-10-06 2018-05-22 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US10046181B2 (en) 2004-10-06 2018-08-14 Guided Therapy Systems, Llc Energy based hyperhidrosis treatment
CN108709623A (zh) * 2018-04-26 2018-10-26 上海交通大学 光声透镜的制作方法、聚焦超声器件及聚焦超声量测系统
US10420960B2 (en) 2013-03-08 2019-09-24 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US10537304B2 (en) 2008-06-06 2020-01-21 Ulthera, Inc. Hand wand for ultrasonic cosmetic treatment and imaging
US10603521B2 (en) 2014-04-18 2020-03-31 Ulthera, Inc. Band transducer ultrasound therapy
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11224895B2 (en) 2016-01-18 2022-01-18 Ulthera, Inc. Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US11241218B2 (en) 2016-08-16 2022-02-08 Ulthera, Inc. Systems and methods for cosmetic ultrasound treatment of skin
US11338156B2 (en) 2004-10-06 2022-05-24 Guided Therapy Systems, Llc Noninvasive tissue tightening system
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US11944849B2 (en) 2018-02-20 2024-04-02 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
US12076591B2 (en) 2018-01-26 2024-09-03 Ulthera, Inc. Systems and methods for simultaneous multi-focus ultrasound therapy in multiple dimensions
US12102473B2 (en) 2008-06-06 2024-10-01 Ulthera, Inc. Systems for ultrasound treatment
US12377293B2 (en) 2019-07-15 2025-08-05 Ulthera, Inc. Systems and methods for measuring elasticity with imaging of ultrasound multi-focus shearwaves in multiple dimensions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278303A1 (fr) * 1987-02-04 1988-08-17 Siemens Aktiengesellschaft Lithotriteur à balayage sectoriel intégré
EP0280088A1 (fr) * 1987-02-16 1988-08-31 Siemens Aktiengesellschaft Générateur de son pour le traitement d'un être vivant avec des ondes sonores focalisées

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278303A1 (fr) * 1987-02-04 1988-08-17 Siemens Aktiengesellschaft Lithotriteur à balayage sectoriel intégré
EP0280088A1 (fr) * 1987-02-16 1988-08-31 Siemens Aktiengesellschaft Générateur de son pour le traitement d'un être vivant avec des ondes sonores focalisées

Cited By (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725494A (en) * 1995-11-30 1998-03-10 Pharmasonics, Inc. Apparatus and methods for ultrasonically enhanced intraluminal therapy
US5728062A (en) * 1995-11-30 1998-03-17 Pharmasonics, Inc. Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers
US5735811A (en) * 1995-11-30 1998-04-07 Pharmasonics, Inc. Apparatus and methods for ultrasonically enhanced fluid delivery
US5846218A (en) * 1996-09-05 1998-12-08 Pharmasonics, Inc. Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US6287272B1 (en) 1996-09-05 2001-09-11 Pharmasonics, Inc. Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US6464660B2 (en) 1996-09-05 2002-10-15 Pharmasonics, Inc. Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US6221038B1 (en) 1996-11-27 2001-04-24 Pharmasonics, Inc. Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers
US5931805A (en) * 1997-06-02 1999-08-03 Pharmasonics, Inc. Catheters comprising bending transducers and methods for their use
US6228046B1 (en) 1997-06-02 2001-05-08 Pharmasonics, Inc. Catheters comprising a plurality of oscillators and methods for their use
US7637877B2 (en) 2003-04-16 2009-12-29 Siemens Aktiengesellschaft Ultrasonic shock wave head for use in lithotripsy
US11590370B2 (en) 2004-09-24 2023-02-28 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US10328289B2 (en) 2004-09-24 2019-06-25 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US9895560B2 (en) 2004-09-24 2018-02-20 Guided Therapy Systems, Llc Methods for rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US10252086B2 (en) 2004-10-06 2019-04-09 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11235180B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US11717707B2 (en) 2004-10-06 2023-08-08 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US11697033B2 (en) 2004-10-06 2023-07-11 Guided Therapy Systems, Llc Methods for lifting skin tissue
US11400319B2 (en) 2004-10-06 2022-08-02 Guided Therapy Systems, Llc Methods for lifting skin tissue
US9522290B2 (en) 2004-10-06 2016-12-20 Guided Therapy Systems, Llc System and method for fat and cellulite reduction
US9533175B2 (en) 2004-10-06 2017-01-03 Guided Therapy Systems, Llc Energy based fat reduction
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US9694211B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US9707412B2 (en) 2004-10-06 2017-07-18 Guided Therapy Systems, Llc System and method for fat and cellulite reduction
US9713731B2 (en) 2004-10-06 2017-07-25 Guided Therapy Systems, Llc Energy based fat reduction
US11338156B2 (en) 2004-10-06 2022-05-24 Guided Therapy Systems, Llc Noninvasive tissue tightening system
US9827450B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. System and method for fat and cellulite reduction
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US9833640B2 (en) 2004-10-06 2017-12-05 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment of skin
US9833639B2 (en) 2004-10-06 2017-12-05 Guided Therapy Systems, L.L.C. Energy based fat reduction
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US9974982B2 (en) 2004-10-06 2018-05-22 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US10010725B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, Llc Ultrasound probe for fat and cellulite reduction
US10010724B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US10010721B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, L.L.C. Energy based fat reduction
US10010726B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US10046182B2 (en) 2004-10-06 2018-08-14 Guided Therapy Systems, Llc Methods for face and neck lifts
US10046181B2 (en) 2004-10-06 2018-08-14 Guided Therapy Systems, Llc Energy based hyperhidrosis treatment
US11207547B2 (en) 2004-10-06 2021-12-28 Guided Therapy Systems, Llc Probe for ultrasound tissue treatment
US10238894B2 (en) 2004-10-06 2019-03-26 Guided Therapy Systems, L.L.C. Energy based fat reduction
US10245450B2 (en) 2004-10-06 2019-04-02 Guided Therapy Systems, Llc Ultrasound probe for fat and cellulite reduction
US11179580B2 (en) 2004-10-06 2021-11-23 Guided Therapy Systems, Llc Energy based fat reduction
US10265550B2 (en) 2004-10-06 2019-04-23 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11167155B2 (en) 2004-10-06 2021-11-09 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US10960236B2 (en) 2004-10-06 2021-03-30 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US10525288B2 (en) 2004-10-06 2020-01-07 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US10532230B2 (en) 2004-10-06 2020-01-14 Guided Therapy Systems, Llc Methods for face and neck lifts
US10888716B2 (en) 2004-10-06 2021-01-12 Guided Therapy Systems, Llc Energy based fat reduction
US10603519B2 (en) 2004-10-06 2020-03-31 Guided Therapy Systems, Llc Energy based fat reduction
US10888717B2 (en) 2004-10-06 2021-01-12 Guided Therapy Systems, Llc Probe for ultrasound tissue treatment
US10603523B2 (en) 2004-10-06 2020-03-31 Guided Therapy Systems, Llc Ultrasound probe for tissue treatment
US10610706B2 (en) 2004-10-06 2020-04-07 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US10610705B2 (en) 2004-10-06 2020-04-07 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US10888718B2 (en) 2004-10-06 2021-01-12 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
JP2012050836A (ja) * 2005-01-10 2012-03-15 Chongqing Haifu (Hifu) Technology Co Ltd 集積超音波療法トランスデューサアセンブリ
US8251929B2 (en) 2005-01-10 2012-08-28 Chongqing Haifu (Hifu) Technology Co., Ltd. Integrated ultrasound therapy transducer assembly
WO2006072199A1 (fr) * 2005-01-10 2006-07-13 Chongqing Haifu(Hifu)Technology Co., Ltd Appareil a transducteur integral pour traitement ultrasonore
EP1837052A4 (fr) * 2005-01-10 2009-08-05 Chongqing Haifu Hifu Tech Co Appareil a transducteur integral pour traitement ultrasonore
RU2370290C2 (ru) * 2005-01-10 2009-10-20 Чонгцинг Хайфу(Хифу)Текнолоджи Ко., Лтд. Интегрированная сборка преобразователя для ультразвуковой терапии
KR100895359B1 (ko) 2005-01-10 2009-04-29 총칭 하이푸 테크놀로지 코 엘티디 일체식의 초음파 치료 변환기 조립체
US12102473B2 (en) 2008-06-06 2024-10-01 Ulthera, Inc. Systems for ultrasound treatment
US10537304B2 (en) 2008-06-06 2020-01-21 Ulthera, Inc. Hand wand for ultrasonic cosmetic treatment and imaging
US11123039B2 (en) 2008-06-06 2021-09-21 Ulthera, Inc. System and method for ultrasound treatment
US11723622B2 (en) 2008-06-06 2023-08-15 Ulthera, Inc. Systems for ultrasound treatment
JP2013527782A (ja) * 2010-04-22 2013-07-04 ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション 結石を検出し、その除去を促進する超音波ベースの方法及び装置
JP2013146550A (ja) * 2011-12-16 2013-08-01 Siemens Medical Solutions Usa Inc 磁気共鳴を用いた超音波治療
FR2984172A1 (fr) * 2011-12-16 2013-06-21 Siemens Medical Solutions Systeme de therapie par ultrason pour une utilisation avec un systeme a resonance magnetique
US9802063B2 (en) 2012-09-21 2017-10-31 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
US11969609B2 (en) 2013-03-08 2024-04-30 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US12478807B2 (en) 2013-03-08 2025-11-25 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US10420960B2 (en) 2013-03-08 2019-09-24 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US11517772B2 (en) 2013-03-08 2022-12-06 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US11351401B2 (en) 2014-04-18 2022-06-07 Ulthera, Inc. Band transducer ultrasound therapy
US10603521B2 (en) 2014-04-18 2020-03-31 Ulthera, Inc. Band transducer ultrasound therapy
US11224895B2 (en) 2016-01-18 2022-01-18 Ulthera, Inc. Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
US11241218B2 (en) 2016-08-16 2022-02-08 Ulthera, Inc. Systems and methods for cosmetic ultrasound treatment of skin
US12076591B2 (en) 2018-01-26 2024-09-03 Ulthera, Inc. Systems and methods for simultaneous multi-focus ultrasound therapy in multiple dimensions
US11944849B2 (en) 2018-02-20 2024-04-02 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
CN108709623A (zh) * 2018-04-26 2018-10-26 上海交通大学 光声透镜的制作方法、聚焦超声器件及聚焦超声量测系统
US12377293B2 (en) 2019-07-15 2025-08-05 Ulthera, Inc. Systems and methods for measuring elasticity with imaging of ultrasound multi-focus shearwaves in multiple dimensions

Also Published As

Publication number Publication date
AU1889595A (en) 1995-09-25

Similar Documents

Publication Publication Date Title
WO1995024159A1 (fr) Appareil de destruction non invasive des tissus au moyen d'ultrasons
US4539989A (en) Injury-free coupling and decoupling of therapeutic shock waves
US4928672A (en) Shockwave source having a centrally disposed ultrasound locating system
US3237623A (en) Apparatus for destroying limited groups of cells
RU2201169C2 (ru) Нейрохирургическое ультразвуковое устройство
Hüter et al. An ultrasonic method for outlining the cerebral ventricles
JP2020512023A (ja) 音響レンズ及びそのアプリケーション
JPH0678944A (ja) 超高速体外超音波温熱療法用装置およびその設定方法
JPH03251240A (ja) 超音波治療装置
JPH07505793A (ja) 熱効果およびキャビテーション効果を有する超音波を出力する超音波治療装置
US6778848B1 (en) Device for the ultrasonic therapy of a female breast with parallel sound direction
JPH10216140A (ja) 超音波治療システム
WO2005107600A1 (fr) Amelioration d'une cavitation acoustique
KR101424506B1 (ko) 초음파 프로브 장치, 초음파 치료 시스템 및 초음파 치료 시스템 제어 방법
US5228447A (en) Shockwave generator having an ultrasound applicator shielded from shockwaves
US4926857A (en) Device for treating life forms with two different types of focused acoustical waves
CN114259279B (zh) 一种能够产生冲击波或超声波的治疗装置
WO2012153888A1 (fr) Applicateur pour ultrasons focalisés de haute intensité
JPH10192289A (ja) 超音波治療装置
Kim et al. Lesion generation through ribs using histotripsy therapy without aberration correction
CN111110280A (zh) 一种超声诊疗系统
KR20020047448A (ko) 초음파 발생기
KR102415740B1 (ko) 탈부착이 가능한 음향 렌즈를 이용한 초음파 진단-치료 장치
JP3644644B2 (ja) 超音波治療装置
EP1885319B1 (fr) Dispositif de destruction de cellules neoplasiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT RO RU SD SE SG SI SK TJ TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA